Literature DB >> 6237713

Immobilisation hypercalcaemia in adults and treatment with clodronate.

A J Yates, T H Jones, K I Mundy, R V Hague, C B Brown, D Guilland-Cumming, J A Kanis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6237713      PMCID： PMC1443249          DOI： 10.1136/bmj.289.6452.1111

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Immobilization hypercalcemia.

Authors:  L van Zuiden; K A Anquist; N Schachar; N Kastelen
Journal:  Can J Surg       Date:  1982-11       Impact factor: 2.089

2.  Serum ionized calcium during bed rest in fracture patients and normal men.

Authors:  H Heath; J M Earll; M Schaaf; J T Piechocki; T K Li
Journal:  Metabolism       Date:  1972-07       Impact factor: 8.694

3.  Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.

Authors:  D L Douglas; T Duckworth; R G Russell; J A Kanis; C J Preston; F E Preston; M A Prenton; J S Woodhead
Journal:  Lancet       Date:  1980-05-17       Impact factor: 79.321
  3 in total
  9 in total

Review 1.  Immobilization osteoporosis: a review.

Authors:  P Minaire
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

2.  Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.

Authors:  S J Gallacher; S H Ralston; F J Dryburgh; F C Logue; B F Allam; B F Boyce; I T Boyle
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

3.  Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.

Authors:  H D McIntyre; D P Cameron; S M Urquhart; W E Davies
Journal:  Postgrad Med J       Date:  1989-04       Impact factor: 2.401

Review 4.  Complications of immobilization and bed rest. Part 2: Other complications.

Authors:  R Teasell; D K Dittmer
Journal:  Can Fam Physician       Date:  1993-06       Impact factor: 3.275

5.  Hypercalcaemia complicating polyneuropathy.

Authors:  T H Jones; J A Kanis; A J Yates
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-04       Impact factor: 10.154

Review 6.  Medical management of hypercalcaemia.

Authors:  S H Ralston
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

7.  Clinical experience with pamidronate in the treatment of Paget's disease of bone.

Authors:  S J Gallacher; B F Boyce; U Patel; A Jenkins; S H Ralston; I T Boyle
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

8.  Aminohydroxypropylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patient.

Authors:  N Varache; M Audran; P Clochon; A Lortholary; G Bouachour; P Alquier; M F Basle
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

Review 9.  Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  G L Plosker; K L Goa
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.